The MarketWatch News Department was not involved in the creation of this content. New patent-pending technology helps creators reduce risk and make smarter creative decisions before content goes live.

Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces the official launch of the ...

GERMANTOWN, MD AND CHICAGO, IL / ACCESS Newswire / December 16, 2025 / uBriGene Biosciences, a leading global lentivirus CDMO specializing in Advanced Therapy Medicinal Product (ATMP) GMP development ...

The New Jersey Artificial Intelligence Hub today announced that it will launch an AI Accelerator, powered by the global innovation platform Plug and Play, early next year. The AI Accelerator will ...

WEST WINDSOR, N.J., Dec. 15, 2025 /PRNewswire/ -- The New Jersey Artificial Intelligence Hub today announced that it will launch an AI Accelerator, powered by the global innovation platform Plug and ...

Deployment addresses the $1 billion antibody-reproducibility crisis by enabling rapid, objective validation of research reagents, reducing wasted time and cost in research and drug development.

Microsoft Gives All Eligible PCs the Green Light for Windows 11 25H2 Your email has been sent Following the end of support for Windows 10, Microsoft is making a concerted effort to move its vast user ...

ATLANTA, GEORGIA / ACCESS Newswire / December 3, 2025 / OMP is helping McCormick & Co., the global leader in flavor, with an AI-driven and autonomous operational planning initiative. This partnership ...

ATLANTA, GEORGIA / ACCESS Newswire / December 3, 2025 / OMP is helping McCormick & Co., the global leader in flavor, with an AI-driven and autonomous operational planning initiative. This partnership ...

Through its partnership with OMP, McCormick is implementing autonomous, decision-centric planning powered by agentic AI to transform how production and inventory are managed. The solution enables ...